ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02477826
Brief Title: An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC) (CheckMate 227)

First Submitted : June 18, 2015
First Submitted that Met QC Criteria : June 18, 2015
First Posted : June 23, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : September 12, 2018
Last Update Posted : September 14, 2018